Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Trump and Kennedy pushed unproven leucovorin for autism, causing a 71% prescription surge; FDA later clarified it's only approved for a rare condition with no evidence for autism.
In 2025, President Trump and HHS Secretary Robert F. Kennedy Jr. promoted leucovorin as a potential autism treatment, triggering a 71% rise in prescriptions for children.
The FDA later clarified the drug is only approved for cerebral folate deficiency, a rare condition, and emphasized there is no scientific evidence supporting its use for autism.
The reversal followed concerns over flawed studies and lack of large-scale trials, prompting warnings from medical experts about promoting unproven therapies.
The episode raised questions about the influence of political figures on public health decisions and the importance of evidence-based medicine.
Trump y Kennedy empujaron la leucovorina no probada para el autismo, causando un aumento del 71% en las recetas; La FDA aclaró más tarde que solo está aprobada para una condición rara sin evidencia de autismo.